Opportunities for Machine Learning and Artificial Intelligence to Advance Synthetic Drug Substance Process Development
Organic Process Research & Development · 17.11.2023 · 27 (11) · 1868-1879
DOI: 10.1021/acs.oprd.3c00229 ↗Kurz gefasst
Fachartikel in der Zeitschrift Organic Process Research & Development, online erschienen am 25.09.2023. Verfasst von Daniel J. Griffin und 4 weiteren Autor:innen. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Griffin, D. J., Coley, C. W., Frank, S. A., Hawkins, J. M., & Jensen, K. F. (2023). Opportunities for Machine Learning and Artificial Intelligence to Advance Synthetic Drug Substance Process Development. Organic Process Research & Development, 27(11), 1868-1879. https://doi.org/10.1021/acs.oprd.3c00229
Vancouver
Griffin DJ, Coley CW, Frank SA, Hawkins JM, Jensen KF. Opportunities for Machine Learning and Artificial Intelligence to Advance Synthetic Drug Substance Process Development. Organic Process Research & Development. 2023;27(11):1868-1879. doi:10.1021/acs.oprd.3c00229
BibTeX
@article{Griffin2023,
author = {Griffin, Daniel J. and Coley, Connor W. and Frank, Scott A. and Hawkins, Joel M. and Jensen, Klavs F.},
title = {Opportunities for Machine Learning and Artificial Intelligence to Advance Synthetic Drug Substance Process Development},
journal = {Organic Process Research & Development},
year = {2023},
volume = {27},
number = {11},
pages = {1868--1879},
doi = {10.1021/acs.oprd.3c00229}
}
EUVIMED